cis-8,11,14-Eicosatrienoic Acid
cis-8,11,14-Eicosatrienoic Acid Brand names, cis-8,11,14-Eicosatrienoic Acid Analogs
cis-8,11,14-Eicosatrienoic Acid Brand Names Mixture
- No information avaliable
cis-8,11,14-Eicosatrienoic Acid Chemical_Formula
C20H34O2
cis-8,11,14-Eicosatrienoic Acid RX_link
No information avaliable
cis-8,11,14-Eicosatrienoic Acid fda sheet
cis-8,11,14-Eicosatrienoic Acid msds (material safety sheet)
cis-8,11,14-Eicosatrienoic Acid Synthesis Reference
No information avaliable
cis-8,11,14-Eicosatrienoic Acid Molecular Weight
306.487 g/mol
cis-8,11,14-Eicosatrienoic Acid Melting Point
No information avaliable
cis-8,11,14-Eicosatrienoic Acid H2O Solubility
No information avaliable
cis-8,11,14-Eicosatrienoic Acid State
Solid
cis-8,11,14-Eicosatrienoic Acid LogP
5.566
cis-8,11,14-Eicosatrienoic Acid Dosage Forms
No information avaliable
cis-8,11,14-Eicosatrienoic Acid Indication
For nutritional supplementation, also for treating dietary shortage or imbalance
cis-8,11,14-Eicosatrienoic Acid Pharmacology
Dihomo gamma-linolenic acid or DHLA is an n-6 (omega-6) polyunsaturated fatty acid. It is comprised of 20 carbon atoms and three double bonds. DHLA is a byproduct of the 18 carbon gamma-linolenic acid (GLA). DHLA is then converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect.
cis-8,11,14-Eicosatrienoic Acid Absorption
No information avaliable
cis-8,11,14-Eicosatrienoic Acid side effects and Toxicity
No information avaliable
cis-8,11,14-Eicosatrienoic Acid Patient Information
No information avaliable
cis-8,11,14-Eicosatrienoic Acid Organisms Affected
Humans and other mammals
